1Arai H,Yamamoto A,Matsuzawa Y,et al.Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000[J].J Atheroscler Thromb,2005,12(5):240-250.
2Hsu LA,Ko YL,Hsu KH,et al.Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwan Residents Chinese[J].Hum Genet,2002,110(1):57-63.
3Choi HS,Park JB,Han KO,et al.A common mutation in cholesteryl ester transfer protein gene and plasma HDL cholesterol level before and after hormone replacement therapy in Korean postmenopausal women[J].Korean J Intern Med,2002,17(2):83-87.
4Freeman DJ,Samani NJ,Wilson V,et al.A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study[J].Eur Heart J,2003,24(20):1833-1842.
5Manjusha Dixit,Sandeep Bhattacharya,Balraj Mittal.Association of CETP TaqI and APOE polymorphisms with type Ⅱ diabetes mellitus in North Indians:a case control study[J].BMC Endocr Disord,2005,5:7.
6Boekholdt SM,Kuivenhoven JA,Hovingh GK,et al.CETP gene variation:relation to lipid parameters and cardiovascular risk[J].Curr Opin Lipidol,2004,15(4):393-398.
7Thompson JF,Durham LK,Lira ME,et al.CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease[J].Atherosclerosis,2005,181(1):45-53.
8Brousseau ME,O'Connor JJ Jr,Ordovas JM,et al.Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency:Veterans Affairs HDL Cholesterol Intervention Trial[J].Arterioscler Thromb Vasc Biol,2002,22(7):1148-1154.
9Frisdal E,Klerkx AH,Le Goff W,et al.Functional interaction between-629C/A,-971G/A and-1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study[J].Hum Mol Genet,2005,14(18):2607-2618.
10Kakko S,Tamminen M,Paivansalo M,et al.Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness[J].Eur J Clin Invest,2001,31:593-602.
3Ford ES, Zhao G, Tsai J, et al. Low-risk lifestyle behaviors and a}l-cause mortality: findings from the National Health and Nutrition Examination Survey II1 Mortality Study[J]. Am J Public Health~ 201L, !.01 ( ~0 ) : 1922-~929.
4Mozumdar A, Liguori G. Persistent increase' of prevalence of metabolic syndrome among U. S. aduhs: NHA]51ES IH to NHANES ~999-2006 [ J]. Diabetes Care, 2011,34( 1 ) :216-219.
5Garcez MR, Pereira JL, Fontane~i MM, et al. Prevalertce of dyslipidemia according to the nutritional status in a representative sample of S~ao Phulo[ J ]. Arq Bras CaxdM, 2014, I03 (6) :475- 484.
6Ozsait B, K~mtircti BE, Poda M, et al. CETP TaqIB polymorphism in Turkish adults: association with dyslipidemia and metabolic syndrome [ J]. Anadolu Kardlyol Derg, 2008,8 (5): 324-330.
7Lu H, Inaz~ A, Moriyama Y, et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism[ J]. J Mol Med( Bed), 2003, 81 (4 ~ :246-255. DO1:10. 1007/s00109-002~14-7.
8DUllaart RP, Sluiter WJ. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis [ J ]. Pharmacogenomics, 2008,9 (6 ~ : 747-763.
9Barter PJ, Kastelein JJ. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease[ Jl. J Am Coil Cardio~, 2006,47 (3) :492-499.
10Namboodiri KK, Green PP, Kaplan EB, et al. The Collaborative Lipid Research. Clinics Program Family Study. IV. Famiiial associations of plasma lipids and: lipoproteins [ J 1. Am J EpidemioI, 1984,H9(6):975-996.
